1. Endothelium-dependent acetylcholine-mediated relaxations of small coronary arteries (-200 pm internal diameter) from 20 weeks old spontaneously hypertensive rats (SHR) and normotensive WistarKyoto oncy) controls were compared under pressurized no-flow conditions after the development of myogenic tone or constriction with the thromboxane AZ mimetic U46619.
4. These data demonstrate that, under control conditions, SHR and WKY coronary arteries relax equally effectively, regardless of mode of contraction, and also that the mechanism of acetylcholinemediated relaxation differs according to the mode of contraction. Acetylcholine relaxes myogenic tone by a K+-sensitive mechanism in both WKY and SHR, consistent with a role for endothelium-derived hyperpolarizing factor; NO contributes substantially to the relaxation of U46619-induced tone by acetylcholine in the WKY, but to a diminished extent in the SHR.
INTRODUCTION
Endothelium-dependent relaxations of vascular smooth muscle are mediated by mechanisms that are sensitive to inhibition of nitric oxide synthase (NOS), and mechanisms insensitive to such inhibition but which can be attenuated by raised extracellular potassium ion concentration or potassium channel inhibition; thus both NO and endotheliumderived hyperpolarizing factor (EDHF) mediate this vascular response (for reviews see [l, 21) .
Endothelium-dependent relaxations are impaired in isolated small arteries from the spontaneously hypertensive rat (SHR), compared with those of Wistar-Kyoto rat (WKY) normotensive controls, as a consequence of reduced NO-mediated relaxations [3-51 and production of endothelium-derived vasoconstrictor prostaglandins [3, 6, 71 . Acetylcholinemediated relaxations of SHR-isolated coronary arteries have been reported to be impaired [S, 91 or normal [lo] . However, abnormal relaxations in response to acetylcholine are not apparent under all conditions [ll] , and the mode of contraction influences the mechanism of relaxation [12] . Therefore the choice of vasoconstrictor agonist could be of critical concern when considering the question of endothelium-dependent relaxation in hypertension.
The purpose of this study was to compare the acetylcholine-mediated relaxations of isolated coronary arteries from SHR and WKY controls and to determine the mechanism of the relaxation subsequent to two different modes of contraction. Accordingly, acetylcholine was applied after the arterial segments developed spontaneous myogenic tone or after the application of U46619 (a stable thromboxane A2 analogue).
METHODS
Male WKY and SHR aged 4 weeks were obtained from Charles River, Margate, Kent, U.K., housed 4-6 per cage and maintained on tap water and standard rat chow ad libitum. All procedues were performed in accordance with our Institutional Guidelines and the U.K. Animals (Scientific Procedures) Act 1986.
Blood pressure determination
At 20 weeks of age a subgroup of each rat strain was subjected to left femoral artery cannulation under anaesthesia, to permit direct blood pressure measurement, as previously described in detail [ 131. Anaesthesia was induced with a combination of Hypnorm and Hypnovel and rats received (per kg, intraperitoneally) 0.26 mg of fentanyl citrate, 8.25 mg of fluanisone and 4.1 mg of midazolam. Analgesia was provided by Temgesic (buprenorphine 0.3 mg/kg, intramuscularly). Blood pressure recordings were made under quiet resting conditions 24 h after surgery while the rats were conscious and unrestrained.
Arterial preparation
Rats that underwent cannulation were used within 1 week of blood pressure measurement. The remainder were 20-24 weeks old. Animals were killed by a stunning blow to the head followed by cervical dislocation. The heart was excised following a thoracic incision and placed in ice-cold physiological salt solution (PSS). The solution contained (in mmol/l) NaCl 119, KCl 4.7, NaHC03 25, MgS04 1.17, KH2P04 1.18, K2EDTA 0.026, glucose 5.5 and CaCh 2.5. The right ventricle was opened and a branch of the septa1 artery dissected free. Only one artery was used from each rat, except where indicated. The artery was placed in the chamber of a Living Systems Instrumentation pressure arteriograph [14] containing cold PSS, cannulated onto two glass micropipettes and secured with nylon suture as previously described [ 131. After confirmation of the absence of leaks, the artery was warmed to 37°C while subject to a transmural pressure of 100 mmHg. This pressure was chosen because SHR and WKY coronary arteries generate similar levels of myogenic tone at 100 mmHg transmural pressure [15] . Pressure was controlled using a pressure servo-control unit (Living Systems). The superfusion fluid reservoir was continuously bubbled with 5% CO2/95% 0 2 and the artery was superfused at 20ml*min-' with a peristaltic pump. Arterial lumen diameters and wall thicknesses were measured using a Living Systems video dimension analyser. Intraluminal pressure and internal diameter were continuously recorded on a two-channel chart recorder. Where indomethacin, or indomethacin in combination with N,,-nitro-L-arginine (L-"A), was used these inhibitors of cyclo-oxygenase and NO synthase (NOS) respectively were present in both intraluminal and extraluminal PSS.
Protocol 1: spontaneous myogenic tone. After cannulation and pressurization, arteries were left to develop spontaneous myogenic tone. Arteries which did not develop tone were discarded and a new artery was used. Acetylcholine (0.01-10 pmol/l) was added to the superfusate in a cumulative manner in the absence of any inhibitors, or in the presence of indomethacin (10 pmol/l), or with indomethacin and Nu-nitro-L-arginine (L-NNA) (10 pmol/l and 0.1 mmol/l respectively). Since NOS inhibitors can increase tone consequent to activation of the cyclooxygenase pathway [16-191, in addition to NOS inhibitory effects, L-NNA was always applied in the presence of indomethacin. Each successive acetylcholine concentration was applied after 2 min if no response occurred, or after the response had peaked.
Only one acetylcholine concentration-response relationship was determined for each artery because preliminary experiments indicated that responsiveness to the agonist decreased with successive challenges. At the end of each experiment the maximum relaxed diameter was determined after replacing the superfusate with calcium-free PSS with 2 mmol/l EGTA. For some arteries the superfusing PSS was exchanged for a PSS with a [K+] of 30 mmol/l (GO) after myogenic tone development. IGo was made by equimolar substitution of NaCl with KCl and was thus isotonic. Unpublished work from this laboratory has demonstrated that an intact endothelium is required for acetylcholine-mediated relaxations in these arteries and that indomethacin and L-NNA have no vasoactive influence on endotheliumdenuded arteries.
Protocol 2: U46619-induced tone. This series of experiments was performed in a similar fashion to protocol 1 except that arteries were constructed with U46619 (1 pmol/l) before the development of myogenic tone. Two arteries were obtained from most rats used in this series, and where this occurred the arteries were randomly assigned to the different treatments. No rat provided two arteries for the same group.
Drugs and chemicals
All drugs were purchased from Sigma Chemical Company (Poole, Dorset, U.K.). PSS constituents were purchased from BDH Laboratory Supplies (Poole, Dorset, U.K.). Indomethacin (10 mmol/l in ethanol) and L-NNA (10mmol/l in PSS) were prepared on the day of experiment. Acetylcholine (10 mmol/l in distilled water) was kept frozen in 1 ml aliquots until required.
Data analysis
Normalized arterial diameters (D,) were calculated by dividing diameters (D) by the diameter at D, = D/Do. This procedure was used in order to compare relative changes in lumen diameters, rather than actual diameters, to account for differences in the mean diameters of the various groups of arteries and to limit the probability of type I1 statistical errors ensuing from the range of arterial diameters within each group. Mean arterial blood pressure was calculated as diastolic blood pressure plus one-third pulse pressure.
All results are presented as means+SEM, unless statedotherwise.Acetylcho1ineconcentrationresponse curves (Ach CRCs) were compared using repeated measures analysis of variance and, where this procedure indicated differences, normalized diameters at each pressure were compared between strains using Student's two tailed t-test with Bonferroni correction. Maximum relaxations and normalized diameters before acetylcholine treatment within each strain were compared by one-way analysis of variance and, when this indicated a significant difference, the Student-Newman-Keuls test was used to compare individual means. Student's two tailed t-test was used for all other comparisons. Differences were considered statistically significant when
P<0.05.

RESULTS
A total of 53 SHR and 48 WKY were used. SHR were characterized by smaller body weights and lumen diameters and increased blood pressures and wall thicknesses (Table 1) . Table 2 indicates that for control SHR and WKY maximum relaxations were not different with either Subsequent to the development of myogenic tone, Ach CRCs were not significantly different between control SHR and WKY arteries (Fig. 1, upper  panel) . Indomethacin and L-NNA did not significantly influence Ach CRCs (Figs 2 and 3 , upper panels). K3o significantly inhibited relaxations in both strains with myogenic tone (P<O.Ol, Fig. 4 , upper panel); relaxations of SHR and WKY arteries were not different in GO.
Maximum relaxations
After constriction with U46619, Ach CRCs in control WKY and SHR arteries were not significantly different (Fig. 5, upper panel) . Indomethacin (Fig. 7, upper panel) , although the difference between SHR controls and those in indomethacin plus L-NNA was of borderline significance (P = 0.07). In arteries with myogenic tone, normalized diameters were different neither between rat strains (Fig.  1, lower panel) nor within the WKY groups (Fig. 2,  lower panel) . SHR controls were significantly different compared with those in indomethacin and L-NNA (P<O.OS, Fig. 3, lower panel) ; the difference between SHR arteries in the two inhibitors and SHR in indomethacin alone was of borderline significance (P = 0.06; Fig. 3, lower panel) . Basal tone was increased in SHR arteries in the presence of L-NNA (Fig. 3, lower panel) . In K~o , SHR Ach
CRCs were significantly different compared with control SHR (P<O.OOl; Fig. 4 , lower panel) and with WKY in K3o (P<O.Ol; Fig. 4 , lower panel).
WKY controls were not significantliy different to WKY in K3o (Fig. 4, lower panel) . After constriction with U46619, Ach CRCs were significantly different between rat strains (P < 0.01; Fig. 2, lower panel) , with the SHR arteries generating more tone before the challenge with acetylcholine. Within the WKY groups there were no significant differences (Fig. 6 , lower panel) although this is likely to be a consequence of the loss of the concentration dependence in the presence of L-"A. SHR controls (P<O.OOl; Fig. 7 , lower panel) and SHR in indomethacin (P<O.Ol; Fig. 7 , lower panel) were significantly different compared with those in indomethacin and L-"A.
Basal tone was increased in SHR arteries incubated with L-NNA. 
DISCUSSION
The endothelium exerts a considerable vasodilatory influence on the resistance arteries of the coronary vascular bed, because inhibition of NOS increases coronary vascular resistance in functioning hearts in a variety of species [20-231, including man [24] and the rat [25] . In the case of the SHR, NO release from functioning hearts has been reported to be increased [26] , although in a non-working heart in which metabolic demands are kept constant there is a decreased basal NO release and reduced endothelial NOS expression [27] . Isolated coronary arteries can be studied in the absence of flow, and thus true basal release of NO can be assessed. In this regard, basal and acetylcholine-stimulated release of NO is reduced in wire-mounted SHR coronary arteries [8] , although normal acetylcholine-induced relaxations have been reported under these conditions [lo, 281. When arteries are studied under more physiological conditions (pressurized with myogenic tone), the endothelium exerts a greater basal dila- tory influence in SHR small coronary arteries [15] . The results obtained in the present study suggest that SHR arteries are subject to greater basal tone modulation by NO when pressurized to 100 mmHg, because L-NNA increased tone in SHR but not in WKY. Observations from our laboratory have suggested that basal NO release does not significantly influence WKY tone at 100mmHg, although at lower pressures basal NO function is similar in SHR and WKY [28a]. Decreased relaxations in response to acetylcholine and bradykinin have been reported for pressurized SHR coronary arteries also [9] , but this was not confirmed in the present study where the magnitude of the relaxations were not impaired with either mode of contraction. The discrepancy may arise from differences in methodology, although it is apparent that the mode of contraction may be important. In this regard, impaired acetylcholineinduced relaxations subsequent to induction of tone acetylcholine, the SHR relaxations were reduced as a consequence of vasoconstrictor prostaglandin production, but when vasopressin was used to induce tone before challenge with acetylcholine, then no such prostaglandins were produced and SHR relaxations were normal. Therefore it seems that the nature of the mode of constriction is of critical concern. In this regard, noradrenaline-induced contractions of rat mesenteric arteries are associated with some depolarization, and acetylcholine effects relaxation by stimulating NO and EDHF release, but when U46619 is used no depolarization occurs and most of the relaxation can be blocked with inhibitors of NOS [12] . The present study lends further support to the hypothesis that the mode of contraction is critical, because it shows that NOS inhibition can block acetylcholine-induced relaxation subsequent to constriction with U46619, but not subsequent to generation of myogenic tone. Vascular smooth muscle depolarizes, and consequently develops myogenic tone, in response to increases in transmural pressure (for review see [29] ). Therefore the role of NO in the dilatory response appears to be diminished in a depolarized preparation. However, these experiments take these observations fur- ther, because they show that the loss of an NO component in the relaxation is not due to a loss of smooth muscle responsiveness to NO after depolarization, because L-NNA enhanced myogenic tone in the SHR, although confirmation that myogenic tone development in rat coronary arteries is associated with depolarization is required. L-NNA did not enhance myogenic tone in the WKY in this study, but L-NNA does not induce endothelium-dependent contractions of WKY at pressures above 80mmHg
[28a]. It is therefore possible that the influence of the mode of contraction on the mechanism of relaxation is not mediated by a change in the smooth muscle responsiveness to endothelium-derived relaxing factors, but by an alteration in endothelial function. These experiments suggest that acetylcholine does not stimulate NO release in myogenically contracted arteries, whereas it does when tone is induced with U46619. However, an alternative possibility is that EDHF activity is upregulated after NOS inhibition, which compensates for the loss of NO [2, 301, as is the case for prostacyclin [31] . The data also suggest that SHR arteries are characterized by increased basal NO vasodilatory function, in parallel with decreased agonist-induced NO function, at least under the present experimental conditions (i.e. pressurized to 100 mmHg in the absence of flow). It is possible that the dependency of the relaxation mechanism upon the mode of contraction might be specific to acetylcholine. In this regard, it would be of interest to repeat these experiments using other endothelium-dependent agonists. Bradykinin is a potent coronary vasodilator and has been shown to induce smaller relaxations in SHR-isolated pressurized coronary arteries [9] and smaller reductions in SHR coronary vascular resistance [27] than in WKY. However, bradykinin and substance P (0.1 nmol/l-1 ,umol/l) did not effect relaxation of myogenic tone or U46619-induced tone in SHR or WKY under the conditions of the present study in pilot experiments which, although not in agreement with the latter two studies [9, 271 , is in agreement with another study where these peptides did not relax rat coronary arteries [28] .
Considering other models of hypertension, isolated coronary arteries from hypertensive Ren-2 transgenic rats relax normally in response to acetylcholine, but basal NO dilatory function is reduced in comparison with controls [32] . Additionally, small coronary arteries from pigs with a renal model of hypertension display normal endothelium-dependent relaxations in response to bradykinin, substance P and 5-HT [33], which demonstrates that abnormal endothelium-mediated responses are not a consistent feature of the coronary vasculature in hypertension.
In summary, these data demonstrate that acetylcholine-mediated relaxations of SHR coronary arteries are not abnormal in magnitude compared with those from WKY, and also provide further evidence that the mode of contraction influences the mode of endothelium-dependent relaxation. Rat coronary artery myogenic tone is relaxed by acetylcholine by a non-NO, non-prostanoid mechanism that is consistent with a role for EDHF, whereas NO contributes substantially to the relaxation following constriction with U46619 in WKY coronary arteries. Basal NO modulates coronary artery tone in SHR to a greater extent than in WKY under the conditions of this study, but acetylcholine-stimulated NO production contributes less to the acetylcholine-mediated relaxation in this model of hypertension. Therefore these data suggest that the choice of vasoconstrictor agent is of critical concern when assessing mechanisms of endothelium-dependent relaxation of normotensive and hypertensive animals.
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